ReviewCytotherapy2025

Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute's International Cell Therapy Committee.

Takeshi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.